These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37022461)

  • 1. DNA methylation signatures for chromatinopathies: current challenges and future applications.
    Awamleh Z; Goodman S; Choufani S; Weksberg R
    Hum Genet; 2024 Apr; 143(4):551-557. PubMed ID: 37022461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of DNA Methylation Signatures and Classification of Variants in Rare Neurodevelopmental Disorders Using EpigenCentral.
    Awamleh Z; Goodman S; Kallurkar P; Wu W; Lu K; Choufani S; Turinsky AL; Weksberg R
    Curr Protoc; 2022 Nov; 2(11):e597. PubMed ID: 36367395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome.
    Chater-Diehl E; Ejaz R; Cytrynbaum C; Siu MT; Turinsky A; Choufani S; Goodman SJ; Abdul-Rahman O; Bedford M; Dorrani N; Engleman K; Flores-Daboub J; Genevieve D; Mendoza-Londono R; Meschino W; Perrin L; Safina N; Townshend S; Scherer SW; Anagnostou E; Piton A; Deardorff M; Brudno M; Chitayat D; Weksberg R
    BMC Med Genomics; 2019 Jul; 12(1):105. PubMed ID: 31288860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomy of DNA methylation signatures: Emerging insights and applications.
    Chater-Diehl E; Goodman SJ; Cytrynbaum C; Turinsky AL; Choufani S; Weksberg R
    Am J Hum Genet; 2021 Aug; 108(8):1359-1366. PubMed ID: 34297908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes.
    Aref-Eshghi E; Rodenhiser DI; Schenkel LC; Lin H; Skinner C; Ainsworth P; Paré G; Hood RL; Bulman DE; Kernohan KD; ; Boycott KM; Campeau PM; Schwartz C; Sadikovic B
    Am J Hum Genet; 2018 Jan; 102(1):156-174. PubMed ID: 29304373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phenomenal epigenome in neurodevelopmental disorders.
    Ciptasari U; van Bokhoven H
    Hum Mol Genet; 2020 Sep; 29(R1):R42-R50. PubMed ID: 32766754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide epigenetic signatures facilitated the variant classification of the PURA gene and uncovered the pathomechanism of PURA-related neurodevelopmental disorders.
    Xiao B; Dai W; Zhan Y; Qiu W; Zhang H; Liu D; Xu N; Yu Y
    Genet Med; 2024 Aug; 26(8):101167. PubMed ID: 38770750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANKRD11 pathogenic variants and 16q24.3 microdeletions share an altered DNA methylation signature in patients with KBG syndrome.
    Awamleh Z; Choufani S; Cytrynbaum C; Alkuraya FS; Scherer S; Fernandes S; Rosas C; Louro P; Dias P; Neves MT; Sousa SB; Weksberg R
    Hum Mol Genet; 2023 Apr; 32(9):1429-1438. PubMed ID: 36440975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature.
    Rots D; Chater-Diehl E; Dingemans AJM; Goodman SJ; Siu MT; Cytrynbaum C; Choufani S; Hoang N; Walker S; Awamleh Z; Charkow J; Meyn S; Pfundt R; Rinne T; Gardeitchik T; de Vries BBA; Deden AC; Leenders E; Kwint M; Stumpel CTRM; Stevens SJC; Vermeulen JR; van Harssel JVT; Bosch DGM; van Gassen KLI; van Binsbergen E; de Geus CM; Brackel H; Hempel M; Lessel D; Denecke J; Slavotinek A; Strober J; Crunk A; Folk L; Wentzensen IM; Yang H; Zou F; Millan F; Person R; Xie Y; Liu S; Ousager LB; Larsen M; Schultz-Rogers L; Morava E; Klee EW; Berry IR; Campbell J; Lindstrom K; Pruniski B; Neumeyer AM; Radley JA; Phornphutkul C; Schmidt B; Wilson WG; Õunap K; Reinson K; Pajusalu S; van Haeringen A; Ruivenkamp C; Cuperus R; Santos-Simarro F; Palomares-Bralo M; Pacio-Míguez M; Ritter A; Bhoj E; Tønne E; Tveten K; Cappuccio G; Brunetti-Pierri N; Rowe L; Bunn J; Saenz M; Platzer K; Mertens M; Caluseriu O; Nowaczyk MJM; Cohn RD; Kannu P; Alkhunaizi E; Chitayat D; Scherer SW; Brunner HG; Vissers LELM; Kleefstra T; Koolen DA; Weksberg R
    Am J Hum Genet; 2021 Jun; 108(6):1053-1068. PubMed ID: 33909990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome.
    Choufani S; McNiven V; Cytrynbaum C; Jangjoo M; Adam MP; Bjornsson HT; Harris J; Dyment DA; Graham GE; Nezarati MM; Aul RB; Castiglioni C; Breckpot J; Devriendt K; Stewart H; Banos-Pinero B; Mehta S; Sandford R; Dunn C; Mathevet R; van Maldergem L; Piard J; Brischoux-Boucher E; Vitobello A; Faivre L; Bournez M; Tran-Mau F; Maystadt I; Fernández-Jaén A; Alvarez S; García-Prieto ID; Alkuraya FS; Alsaif HS; Rahbeeni Z; El-Akouri K; Al-Mureikhi M; Spillmann RC; Shashi V; Sanchez-Lara PA; Graham JM; Roberts A; Chorin O; Evrony GD; Kraatari-Tiri M; Dudding-Byth T; Richardson A; Hunt D; Hamilton L; Dyack S; Mendelsohn BA; Rodríguez N; Sánchez-Martínez R; Tenorio-Castaño J; Nevado J; Lapunzina P; Tirado P; Carminho Amaro Rodrigues MT; Quteineh L; Innes AM; Kline AD; Au PYB; Weksberg R
    Am J Hum Genet; 2022 Oct; 109(10):1867-1884. PubMed ID: 36130591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Utility of Genome-Wide DNA Methylation Analysis in Mendelian Neurodevelopmental Disorders.
    Haghshenas S; Bhai P; Aref-Eshghi E; Sadikovic B
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Methylation Possible Adjunct to Screening for Neurodevelopmental Syndromes: DNA methylation signatures were identified for several neurodevelopmental Mendelian disorders, and hold promise as a supplement to standard procedures for screening and detection of these diseases.
    Am J Med Genet A; 2018 Apr; 176(4):755-756. PubMed ID: 29575619
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders.
    Aref-Eshghi E; Kerkhof J; Pedro VP; ; Barat-Houari M; Ruiz-Pallares N; Andrau JC; Lacombe D; Van-Gils J; Fergelot P; Dubourg C; Cormier-Daire V; Rondeau S; Lecoquierre F; Saugier-Veber P; Nicolas G; Lesca G; Chatron N; Sanlaville D; Vitobello A; Faivre L; Thauvin-Robinet C; Laumonnier F; Raynaud M; Alders M; Mannens M; Henneman P; Hennekam RC; Velasco G; Francastel C; Ulveling D; Ciolfi A; Pizzi S; Tartaglia M; Heide S; Héron D; Mignot C; Keren B; Whalen S; Afenjar A; Bienvenu T; Campeau PM; Rousseau J; Levy MA; Brick L; Kozenko M; Balci TB; Siu VM; Stuart A; Kadour M; Masters J; Takano K; Kleefstra T; de Leeuw N; Field M; Shaw M; Gecz J; Ainsworth PJ; Lin H; Rodenhiser DI; Friez MJ; Tedder M; Lee JA; DuPont BR; Stevenson RE; Skinner SA; Schwartz CE; Genevieve D; Sadikovic B
    Am J Hum Genet; 2020 Mar; 106(3):356-370. PubMed ID: 32109418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Episignatures Stratifying Helsmoortel-Van Der Aa Syndrome Show Modest Correlation with Phenotype.
    Breen MS; Garg P; Tang L; Mendonca D; Levy T; Barbosa M; Arnett AB; Kurtz-Nelson E; Agolini E; Battaglia A; Chiocchetti AG; Freitag CM; Garcia-Alcon A; Grammatico P; Hertz-Picciotto I; Ludena-Rodriguez Y; Moreno C; Novelli A; Parellada M; Pascolini G; Tassone F; Grice DE; Di Marino D; Bernier RA; Kolevzon A; Sharp AJ; Buxbaum JD; Siper PM; De Rubeis S
    Am J Hum Genet; 2020 Sep; 107(3):555-563. PubMed ID: 32758449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation signature associated with Bohring-Opitz syndrome: a new tool for functional classification of variants in ASXL genes.
    Awamleh Z; Chater-Diehl E; Choufani S; Wei E; Kianmahd RR; Yu A; Chad L; Costain G; Tan WH; Scherer SW; Arboleda VA; Russell BE; Weksberg R
    Eur J Hum Genet; 2022 Jun; 30(6):695-702. PubMed ID: 35361921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants.
    Siu MT; Butcher DT; Turinsky AL; Cytrynbaum C; Stavropoulos DJ; Walker S; Caluseriu O; Carter M; Lou Y; Nicolson R; Georgiades S; Szatmari P; Anagnostou E; Scherer SW; Choufani S; Brudno M; Weksberg R
    Clin Epigenetics; 2019 Jul; 11(1):103. PubMed ID: 31311581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional annotation of genomic variation: DNA methylation episignatures in neurodevelopmental Mendelian disorders.
    Sadikovic B; Levy MA; Aref-Eshghi E
    Hum Mol Genet; 2020 Sep; 29(R1):R27-R32. PubMed ID: 32644126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic signatures in overgrowth syndromes: Translational opportunities.
    Cytrynbaum C; Choufani S; Weksberg R
    Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):491-501. PubMed ID: 31828978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation episignature testing improves molecular diagnosis of Mendelian chromatinopathies.
    Kerkhof J; Squeo GM; McConkey H; Levy MA; Piemontese MR; Castori M; Accadia M; Biamino E; Della Monica M; Di Giacomo MC; Gervasini C; Maitz S; Melis D; Milani D; Piccione M; Prontera P; Selicorni A; Sadikovic B; Merla G
    Genet Med; 2022 Jan; 24(1):51-60. PubMed ID: 34906459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping Conditions.
    Butcher DT; Cytrynbaum C; Turinsky AL; Siu MT; Inbar-Feigenberg M; Mendoza-Londono R; Chitayat D; Walker S; Machado J; Caluseriu O; Dupuis L; Grafodatskaya D; Reardon W; Gilbert-Dussardier B; Verloes A; Bilan F; Milunsky JM; Basran R; Papsin B; Stockley TL; Scherer SW; Choufani S; Brudno M; Weksberg R
    Am J Hum Genet; 2017 May; 100(5):773-788. PubMed ID: 28475860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.